November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

November 19, 2024

Analysis Maps Broad Semaglutide Eligibility

An estimated 136.8 million U.S. adults are eligible for semaglutide, a number exceeding current eligibility for statins, according to an analysis.

Conexiant

November 19, 2024

Lilly Pill Lowers Lp(a) Up to 86%: Study

Reuters

November 14, 2024

AI-Powered Camera Detects Hypertension, Diabetes

Reuters

November 14, 2024

Heat Waves Spike Atrial Fibrillation Risk

Reuters

November 12, 2024

Cholesterol Swings: New Dementia Warning Sign

High fluctuations in total cholesterol were associated with a 60% increase in dementia risk, while stable levels showed significantly lower cognitive decline over six years in a study of 9,846 elderly adults.

Conexiant

November 12, 2024

New Data Links GLP-1s to Poststroke Outcomes

Post-stroke patients taking GLP-1 or SGLT2 medications showed a 74% lower mortality risk and 84% lower heart attack risk over 3 years compared to untreated peers.

Conexiant

November 12, 2024

CKM Could Mean Decades Earlier CVD Risk

Conexiant

November 11, 2024

Cardiac Patients Sought Sex Advice, Found Silence

While 76% of cardiac patients reported sexual health affecting their mood and well-being, only 5% received counseling on the topic, according to new survey data presented at AHA Scientific Sessions 2024.

Conexiant